Buy Seres Therapeutics Stock | MCRB Stock Price & Latest News | Public.com

MCRB

Seres Therapeutics

$0.00 (0.00%)Today

About MCRB

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan...Read more

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.3

Price Targets

What analysts think this stock will be worth

$4.91
current
$8.04
average

Events

List of events that could affect this stock.

07May

Earnings data Q1 2020

06Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.09
-0.19
-0.28
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.26

Actual EPS
Q3 2020

Stats

Market Cap$399,29M
Volume23,91k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$6.75
1 Year Low$2.15
Open$5.48
High$5.48
Low$4.91

Buy any stock with any amount of money.

Download the App
Download the app